A skincare brand launching in 2026 should build authority in the sources AI engines cite before launch day, and should hold every claim to the FDA's line between cosmetic and drug claims. In EPR's Beauty Citation Share Index, the clinical-coded and derm-coded brands CeraVe (91), The Ordinary (87) and SkinCeuticals (78) rank above prestige houses with larger budgets, and the FDA treats claims such as removing wrinkles as drug claims, not cosmetic ones.
Last updated November 19, 2026. Part of EPR's Beauty PR pillar. This guide is general information about marketing and is not legal advice. Have regulatory counsel review claims before launch.
What can a skincare brand claim under FDA rules?
A skincare brand can make cosmetic claims about appearance and moisturizing, and it cannot claim to change the structure or function of skin without meeting drug rules. The FDA's page on wrinkle treatments and other anti-aging products says a product intended to make lines and wrinkles less noticeable by moisturizing is a cosmetic, while a product intended to remove wrinkles or increase the skin's collagen production is a drug or a medical device.
| Claim | Likely category | Why |
| Makes the look of fine lines less noticeable by moisturizing | Cosmetic | FDA treats appearance and moisturizing claims as cosmetic |
| Removes wrinkles | Drug or device | FDA says removing wrinkles affects the structure of the skin |
| Increases collagen production | Drug or device | FDA names this as an example of a structure or function claim |
| Clinically proven | Advertising claim | The FDA page points to the Federal Trade Commission as the regulator of advertising claims, so the study behind the claim should exist before the claim runs |
The FDA does not require cosmetics to be approved before sale, but it warns that anti-aging claims about the skin's structure or function can make a cosmetic a drug. Keep a substantiation file for every claim before launch, and review website copy, product names and social posts together, because the FDA looks at what a company says about a product, not only the label.
How should a skincare launch build authority before day one?
A skincare launch should build presence in five source layers from 90 days to 30 days before launch, so that engines find citable material on launch day. The layers come from EPR's AI Beauty Authority Stack, described in The Claude Beauty Layer. They sit inside the broader 12-week sequence in EPR's product launch playbook, which covers goals, the exclusive, launch day and the 90-day follow-through for any category.
| Layer | Pre-launch work | Output |
| 1. Product and claims | Publish ingredient transparency, clinical results where they exist, manufacturing standards and claim substantiation on your own site, with schema markup | Owned pages engines can quote |
| 2. Editorial | Brief tier-one beauty editors under embargo about 30 days out, and send samples to category reviewers and clinically credible reporters | Launch-day coverage |
| 3. Creator | Lock in three to seven right-fit dermatologists with content scheduled for launch, and build an always-on creator plan | Expert voices outside your own channels |
| 4. Community | Plan founder participation in relevant Reddit communities, Sephora review velocity for a retail launch, and an Amazon review plan for a direct-to-consumer launch | Review and forum presence |
| 5. AI visibility | Publish ingredient explainers and FAQ pages before launch, and compare your citation gaps with the brands in the Beauty Citation Share Index | A list of the brands you compete with for retrieval |
Why do dermatologist relationships matter more than paid posts?
Dermatologist relationships matter because engines cite expert sources, and in EPR's research dermatologist references appear in the cited source stack for most skincare answers. The top of the Beauty Citation Share Index is made up of derm-coded or clinical-coded brands: CeraVe (91), The Ordinary (87) and SkinCeuticals (78). The full ranking is in the Beauty Citation Share Index 2026.
A durable arrangement works better than a one-off endorsement. It includes a clinical advisory group of board-certified dermatologists, co-created educational content, honest assessments the brand does not edit, and a clear disclosure of any paid advisory role. Influencer Fatigue and Credibility-Driven Beauty PR covers the shift toward credibility-led creators.
For a worked example, 5WPR's published Medicube case study reports more than 420 placements in under two years, and 2.5 billion impressions from a Hailey Bieber collaboration within three months. The case study says dermatologist Dr. Dendy Engelman mentioned the brand in Vogue and TODAY Show pieces. Those figures cover different scopes and periods, so do not add them together.
Why does Reddit matter for a skincare launch?
Reddit matters because skincare buyers research there and because Reddit communities are the largest single source in EPR's modeled beauty citation shares, at 16.2%. The numbers are in How Beauty Brands Get Inside the AI Answer Box.
Participate where it adds value: founder question-and-answer sessions, accurate product information in community discussions, and quick replies when product questions arise. Brands that ignore r/SkincareAddiction and related communities give up a source engines read.
What should launch week and the first 90 days look like?
| Window | EPR recommendation |
| Launch week | Tier-one placements go live on embargo, dermatologist and creator content drops in coordinated waves, the founder does broadcast and podcast appearances, community engagement begins, and schema is checked live |
| Days 1 to 90 | Secure at least one or two earned placements a month, rotate creator partners, publish owned content weekly, review citation share against the Index monthly, collect customer reviews, and keep up Reddit participation. See How Beauty Brands Win TikTok for creator sequencing |
These cadences are EPR's recommendations, not measured thresholds. The first 90 days after launch is where many launches lose momentum, because the launch-week coverage ends and no later program takes over.
What has stopped working, and what works now?
Launches without an ingredient story, influencer programs with no dermatologist behind them, clinical claims without substantiation, and thin owned content have stopped working. What works in EPR's view is authority built across all five layers, sustained dermatologist and creator relationships, founder voice on owned channels, owned content engines can quote, and clinical substantiation that survives scrutiny.
The next decision for a launch team is whether every claim has a substantiation file and a regulatory review before the first press brief goes out.